InvestorsHub Logo
Followers 237
Posts 11964
Boards Moderated 0
Alias Born 08/14/2003

Re: fluteman post# 476320

Thursday, 05/19/2022 7:38:23 PM

Thursday, May 19, 2022 7:38:23 PM

Post# of 685953
Can you show me an immuno-therapy that completely cures the illness, DCVax-L certainly isn't one. People living longer will use more, not less products from BP's. It's certainly true that DCVax-L, and hopefully Direct, have great benefits, but they do so working in conjunction with products from BP.

I suppose the stem cells I received for leukemia may be considered an immuno-therapy, but before I could ever receive them I went through all sorts of products from BP and continue on others post stem cells. My point is they complement one another.

Perhaps the day will come when personalized products will account for many cures, but when it happens, you can bet that most of the products will still be coming from BP's who'll be as profitable as ever before. I don't know if we'll ever be bought out by BP, but if not I'd bet they'll still partner and have a major equity interest. Owning 30% of a stock that goes through the roof may well be worth more than 100% of their products.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News